Last updated: 2026-09-16 12:38:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Conexeu Sciences Inc. (CNXU) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $4.50, with a market capitalisation of $141.03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.19 to $18.79. This page covers its latest market performance, valuation, price trends and company information.
$141.03M | |
$4.44 | |
$18.79 | |
$4.19 | |
$4.45 | |
91.00 | |
173.61K | |
-- | |
$18.79 | |
$4.19 | |
-- | |
-- |
Conexeu Sciences Inc. (CNXU) is trading at $4.50 in pre-market trading as of 2026-09-16 12:33:00, up 1.12% ($0.05) from the previous close of $4.45
Pre-market trading shows how investors are pricing CNXU before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Conexeu Sciences Inc. (CNXU) moved from $4.97 to $4.50, representing a decline of 9.46% ($0.47).
The stock traded between $4.19 and $5.58 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 187.84 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.1%
CNXU is currently trading at $4.50, placing it 2.1% of the way from its 52-week low of $4.19 to its 52-week high of $18.79. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Conexeu Sciences Inc. (CNXU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.